Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Puma Biotechnology (NQ: PBYI ) 2.450 -0.010 (-0.41%) Streaming Delayed Price Updated: 9:30 AM EDT, Oct 3, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 2,950 Open 2.450 Bid (Size) 2.440 (5) Ask (Size) 2.490 (5) Prev. Close 2.460 Today's Range 2.450 - 2.450 52wk Range 2.130 - 7.730 Shares Outstanding 47,509,765 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News 12 Health Care Stocks Moving In Tuesday's After-Market Session October 01, 2024 Via Benzinga Puma Biotechnology to Present at the H.C. Wainwright 26th Annual Global Investment Conference September 03, 2024 From Puma Biotechnology, Inc. Via Business Wire Performance YTD -45.86% -45.86% 1 Month +2.94% +2.94% 3 Month -18.87% -18.87% 6 Month -54.21% -54.21% 1 Year -1.61% -1.61% More News Read More Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) August 06, 2024 From Puma Biotechnology, Inc. Via Business Wire Puma Biotechnology Reports Second Quarter Financial Results August 01, 2024 From Puma Biotechnology, Inc. Via Business Wire Where Puma Biotechnology Stands With Analysts July 26, 2024 Via Benzinga Beyond The Numbers: 4 Analysts Discuss Puma Biotechnology Stock June 04, 2024 Via Benzinga Earnings Scheduled For February 29, 2024 February 29, 2024 Via Benzinga Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2024 Financial Results July 18, 2024 From Puma Biotechnology, Inc. Via Business Wire Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) July 02, 2024 From Puma Biotechnology, Inc. Via Business Wire Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) June 07, 2024 From Puma Biotechnology, Inc. Via Business Wire Puma Biotechnology Announces Presentation of Findings from a Phase I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung Cancer June 03, 2024 From Puma Biotechnology, Inc. Via Business Wire Puma Biotechnology Announces Presentation of Findings from a Phase II Study of Alisertib in Endocrine-Resistant Metastatic Breast Cancer (TBCRC 041) June 02, 2024 From Puma Biotechnology, Inc. Via Business Wire Puma Biotechnology to Join Russell 3000 Index May 28, 2024 From Puma Biotechnology, Inc. Via Business Wire Puma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual Meeting May 23, 2024 From Puma Biotechnology, Inc. Via Business Wire Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute May 20, 2024 Via Benzinga Topics Intellectual Property Exposures Intellectual Property PBYI Stock Earnings: Puma Biotechnology Beats EPS, Beats Revenue for Q1 2024 May 02, 2024 Via InvestorPlace Puma Biotechnology Reports First Quarter Financial Results May 02, 2024 From Puma Biotechnology, Inc. Via Business Wire 7 Stocks Under $15 Predicted to Boom in the Next 2 Years April 19, 2024 Via InvestorPlace Puma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial Results April 18, 2024 From Puma Biotechnology, Inc. Via Business Wire Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) April 03, 2024 From Puma Biotechnology, Inc. Via Business Wire Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer March 20, 2024 From Puma Biotechnology, Inc. Via Business Wire 10 Health Care Stocks With Whale Alerts In Today's Session March 19, 2024 Via Benzinga Puma Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results February 29, 2024 From Puma Biotechnology, Inc. Via Business Wire Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) February 27, 2024 From Puma Biotechnology, Inc. Via Business Wire Puma Biotechnology to Participate in a Panel Discussion at TD Cowen’s 44th Annual Health Care Conference February 22, 2024 From Puma Biotechnology, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
